首页> 外文会议>International Conference on Applied Human Factors and Ergonomics >Physiological Evaluation of a Non-invasive Wearable Vagus Nerve Stimulation (VNS) Device
【24h】

Physiological Evaluation of a Non-invasive Wearable Vagus Nerve Stimulation (VNS) Device

机译:非侵入性耐磨迷走神经刺激(VNS)装置的生理学评价

获取原文

摘要

Recent clinical studies suggest that Vagus nerve stimulation (VNS) may be a safe and potentially effective for disorder related to heart. In the rise of wearable medical devices, non-invasive wearable VNS devices are available to treatment of disorders related to the central nervous system. The goal of this study was to investigate the effects of VNS devices on physiological parameters of human. AMO+ is a wearable VNS device that was worn to the neck as a necklace. ECG (Electrocardiogram) and EEG (Electroencephalogram) of 30 healthy persons are measured in Center for Medical Metrology, Korea Research Institute of Standards and Science, Daejeon, South Korea. Wireless Bionomadix (Biopac Systems, Goleta, CA) RSPEC-R used for measuring ECG and EEG2-R as used to measure EEG. EEG electrodes are placed in F3 and F4 position of head as per 10/20 System. Acqknowledge Ver. 14 used for data analysis. EEG α, β, θ, δ power spectrums are extracted from raw EEG signals. HR (Heart Rate), HF (High Frequency), LF (Low Frequency) features are extracted from raw ECG data. Data was taken before using VNS deice and after one hour of using wearable AMO VNS device. All data was taken in resting state. Statistical analysis was done by IBM SPSS Ver. 23.0. No significant difference of HR is found between cases of before using VNS device and after using VNS device. A significant difference found in case of HF power of ECG. As ECG HF power reflects the parasympathetic nervous system activity, HF power increase indicates improvement of parasympathetic nervous system activity. No significant difference of EEG α, β, θ power spectrums except 8 power is found between cases of before using VNS device and after using VNS device. Wearable AMO+ VNS stimulation is expected to improve the parasympathetic nervous system activity.
机译:最近的临床研究表明,迷走神经刺激(VNS)可能是一个安全的和潜在有效的与心脏疾病。在可佩戴的医疗设备的兴起,非侵入性的可穿戴VNS装置可用于治疗与中枢神经系统病症。这项研究的目的是调查VNS设备对人体的生理参数的影响。 AMO +是已佩戴到颈部作为项链的可穿戴设备VNS。 ECG(心电图)和30种健康人的EEG(脑电图)在中心测定,医学计量,标准的韩国研究所和科学,大田,韩国。无线Bionomadix(Biopac系统,Goleta的,CA)用于作为用于测量EEG测量ECG和EEG2-R RSPEC-R。 EEG电极被放置在头的F3和F4位置按10/20系统。 Acqknowledge版本。 14用于数据分析。 EEGα,β,θ,δ功率谱从原始EEG信号中提取。 HR(心率),HF(高频),LF(低频)功能可以从原始ECG数据中提取。数据使用VNS除冰之前和使用可佩戴式AMO VNS装置的一小时后取出。所有数据都被带到静止状态。统计分析是由IBM SPSS版本完成。 23.0。 HR的无显著差异正在使用VNS设备前和使用VNS设备后的情况之间找到。在心电图的高频电力的情况下的显著差异找到。心电图HF功率反映了副交感神经系统活动,HF功率增加指示副交感神经系统活性的提高。 EEGα,β,θ功率谱除8的功率没有显著差异是使用VNS设备之前和使用VNS装置之后的情况之间发现。穿戴式AMO + VNS刺激有望提高副交感神经系统活动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号